Pacira Pharmaceuticals Inc (NASDAQ:PCRX)

Delayed Data
As of Jun 29
 -2.53 / -3.60%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 9 analysts offering 12-month price forecasts for Pacira Pharmaceuticals Inc have a median target of 92.00, with a high estimate of 116.00 and a low estimate of 70.00. The median estimate represents a +35.79% increase from the last price of 67.75.

Analyst Recommendations

The current consensus among 9 polled investment analysts is to Buy stock in Pacira Pharmaceuticals Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Jul 30

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 5.57%
Growthannually 168.86%


Growthquarterly 8.84%
Growthannually 36.54%
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account